Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.
about
Use of contrast agents in oncological imaging: magnetic resonance imaging.Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practiceRituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.Efficient labeling in vitro with non-ionic gadolinium magnetic resonance imaging contrast agent and fluorescent transfection agent in bone marrow stromal cells of neonatal rats.Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?Comparison of Diagnostic Accuracy of MRI with and Without Contrast in Diagnosis of Traumatic Spinal Cord Injuries.Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla.Effect of imaging time in the magnetic resonance detection of intracerebral metastases using single dose gadobutrolMR imaging in multiple sclerosis: review and recommendations for current practice.Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the Peripheral VALUE Study).Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.IMAGING DIAGNOSIS-MAGNETIC RESONANCE IMAGING FEATURES OF A MULTIFOCAL OLIGODENDROGLIOMA IN THE SPINAL CORD AND BRAIN OF A DOG.Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study).Comparative studies of different gadolinium agents in brain tumors: differences between gadolinium chelates and their possible influence on imaging features.Comparison of gadobenate dimeglumine and gadodiamide in the evaluation of spinal vascular anatomy with MR angiography.Multicenter, intraindividual comparison of single-dose gadobenate dimeglumine and double-dose gadopentetate dimeglumine for MR angiography of the supra-aortic arteries (the Supra-Aortic VALUE study).Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer.High Relaxivity Gadolinium-Polydopamine Nanoparticles.Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide.A serial dilution study of gadolinium-based MR imaging contrast agents.The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).Effectiveness of a high relaxivity contrast agent administered at half dose in dynamic susceptibility contrast MRI of brain gliomas.Albumin-binding MR blood pool contrast agent improves diagnostic performance in human brain tumour: comparison of two contrast agents for glioblastoma.Pharmacokinetics of gadobenate dimeglumine in children 2 to 5 years of age undergoing MRI of the central nervous system.Half-dose gadobenate dimeglumine versus standard-dose gadodiamide in dynamic magnetic resonance imaging of non-cirrhotic livers: a retrospective intra-individual crossover comparison.Effect of acquisition time and chemical fat suppression on meningeal enhancement on MR imaging in dogs.Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
P2860
Q30669419-EE081017-8694-46DA-A0B7-7C9E89CC9E38Q33873443-8B4E1866-3F1C-4152-83D8-C97102632B48Q33899917-26844977-8285-4F53-BD04-D101A00585F6Q34053148-1B4FC515-03C7-4490-A2DC-E254924A2440Q35628511-AAFEEB99-DF65-4423-8A03-CB67EF47F926Q36295407-9107CF42-22E3-490E-8981-AAC807427265Q37176412-A5F82C26-6DC6-4B31-898E-13D31E80B8C0Q37314667-02367D73-FA8A-4E94-BA4C-69E72FD70D7FQ37541200-C513728A-0A7F-4654-BF9D-E1CC0EF23ED7Q37658010-1B9FC0D3-CACB-43C0-9C29-3DE4C64DBE73Q38078314-E977E4AA-8210-411D-B525-7E07534F0323Q38213840-C1FD58F8-8DB8-4569-8E72-3EB59F9BDF41Q38411861-24CBCF9E-74EF-491D-97C1-ED5030390415Q39197153-68B4B52B-E031-4712-B8C4-3E3BBF909B4EQ43124662-B67592C5-8D93-4B31-AB2F-E603B2841498Q43201167-4A4E0EE2-BAE3-4A22-9820-01593A67C890Q45173741-203ADEA1-32E0-4237-AEC4-F7464987B1D2Q45931214-DDD21CBE-104A-4A6D-97D6-B2992B8C2710Q45939759-50AEEF0C-046F-4815-AD27-B14AA30DBB53Q46453502-942765F7-4E75-4DBF-B435-7E29D4DBDE5BQ46503239-F364ED6E-DBD8-4716-A1FC-4C70D6B48D9DQ46815679-9EE3B1B7-EEE2-445A-85B1-2B3B5204831CQ48157270-EB0E8BE7-2A4A-47FA-AA9C-AEF574EC54EEQ48177044-D166B897-B663-4C0B-9EE9-35141424F647Q48327483-05325B41-AF24-49CA-8AB1-CACB04E99140Q48786983-6684777C-52D7-4086-AA20-88CF1EF2DFFAQ53072973-0AA48072-8993-4151-B2E3-D684948F1816Q53091491-BD18B1B0-2D6F-4EEA-88EF-8A6C89B4B0ADQ53136942-DFD70E75-F0DB-4C1A-BE65-28397DC7654D
P2860
Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Contrast enhancement of centra ...... udy of two MR contrast agents.
@ast
Contrast enhancement of centra ...... udy of two MR contrast agents.
@en
type
label
Contrast enhancement of centra ...... udy of two MR contrast agents.
@ast
Contrast enhancement of centra ...... udy of two MR contrast agents.
@en
prefLabel
Contrast enhancement of centra ...... udy of two MR contrast agents.
@ast
Contrast enhancement of centra ...... udy of two MR contrast agents.
@en
P2093
P1433
P1476
Contrast enhancement of centra ...... udy of two MR contrast agents.
@en
P2093
Brian C Bowen
Franz J Wippold
Ilona M Schmalfuss
Joseph A Maldjian
Kenneth R Maravilla
Lars Gustafsson
Leo J Wolansky
Marco Essig
Matthew J Kuhn
Michael V Knopp
P304
P356
10.1148/RADIOL.2402051266
P407
P577
2006-06-26T00:00:00Z